Position in ALNY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,009,676
-$1,257,334 QoQ
Shares Held
6,676
-32.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#330
of 784 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Atria Investments, Inc holds $48,565,837 across 44 Biotechnology names. ALNY ranks #3 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,245 | $15,023,598 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,603 | $6,611,394 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
6,676 | $2,009,676 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
56,598 | $2,003,003 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
18,578 | $1,514,292 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
4,667 | $1,475,192 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
18,788 | $1,470,536 | |
| 8 | ASND |
Ascendis Pharma A/S
|
5,344 | $1,425,351 |
All Filings in ALNY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,009,676 | 6,676 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $3,267,010 | 9,874 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,454,693 | 6,173 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,368,464 | 5,194 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,394,360 | 4,276 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,135,164 | 4,204 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $779,111 | 3,311 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $864,969 | 3,145 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $427,194 | 1,758 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||